| Ytd | 196.37% | |
| 1y | 162.38% |
| Open | 95.71 | Prev Close | 95.86 | Low | 94.08 | High | 96.15 | Mkt Cap | 5.97B |
| Vol | 78.94K | Avg Vol | 1.74M | EPS | -2.13 | P/E | -45.00 | Forward P/E | -118.74 |
| Beta | 2.11 | Short Ratio | 6.32 | Inst. Own | 124.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 77.60 | 200-d Avg | 50.23 | 1yr Est | 88.50 |
TWST News
Allspring Global Investments Holdings LLC purchased a new position in shares of Twist Bioscience Cor
Thrivent Small Cap Growth Fund returned 25.54% during the quarter, modestly underperforming the Russ
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap
Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and rai
Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and rais
The researchers said the findings are not causal and urged more research into whether GLP-1s reduce
12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026. All sha
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher th
This synthetic biology innovator, known for its DNA-based solutions, reported a notable insider sale
Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs
This synthetic biology firm, known for silicon-based DNA synthesis, reported a notable insider sale
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap
Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript
DÜSSELDORF, Germany--(BUSINESS WIRE)--LenioBio GmbH, a TechBio company commercializing its ALiCE® ce
Twist Bioscience (TWST) delivered strong Q2 results, driven by AI-enabled drug discovery. NGS growth
Twist Bioscience Corporation (NASDAQ:TWST) on Monday reported a loss for its fiscal 2026 second quar
Top Wall Street analysts changed outlook on top names. Check analyst ratings page for full changes.
Top analysts change outlooks on top names: UBS raises price target for TD Synnex, BMO Capital raises
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, T
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) shares are down on Monday as the company reported its fis
Twist Bioscience (TWST) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Tuesday. Here are some big
During Monday's trading, 1214 companies set new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.